UBS lowered the firm’s price target on Visteon (VC) to $120 from $130 and keeps a Buy rating on the shares. Visteon’s 2026 EBITDA guidance came in 7% below expectations, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VC:
- Visteon price target lowered to $117 from $127 at Deutsche Bank
- Visteon price target lowered to $127 from $140 at RBC Capital
- Visteon price target lowered to $119 from $126 at Baird
- Visteon Posts Strong 2025 Results, Boosts Dividend, Guides 2026
- Visteon sees FY26 revenue $3.63B-$3.84B, consensus $3.87B